RKDA

#5120
Arcadia Biosciences, Inc.
1.33 USD
+0.76%
Settore: Beni di Consumo Difensivi
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
1.33
1.33
Intervallo Annuale
1.30
6.71
Variazione giornaliera
+0.76%
Variazione Mensile
-26.11%
Variazione di 6 mesi
-74.47%
Variazione Annuale
-58.44%
Chiusura Precedente
1.32
Apertura
1.33
Bid
Ask
Minimo
1.33
High
1.33
Volume
13
Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche
Trimestrale Annuale
  • Market Capitalization 2.74 M
  • Employee 8
  • Founded 2002
  • CEO N/A
  • Website www.arcadiabio.com
  • Headquarter Delaware, United States
  • FIGI BBG000GYBX66
  • Industry Technology
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-1.16
Rapporto prezzo/fatturato
0.53

Arcadia Biosciences Inc

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation. It has developed a reduced-gluten and enhanced starch variety of wheat under the name GoodWheat. Arcadia also has a joint venture with Bioceres called Verdeca, which has developed and is commercializing HB4 technology in soybeans that gained FDA approval in 2017. HB4 soybeans have increased yield up to 30% while being more resistant to abiotic stress such as drought.

Notizie